Fundz

Praesidia Biotherapeutics reported raising $500,000 in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEApr 08, 2024$500K of $15M raised

Amount Raised

$500,000

$500,000 sold, per SEC Form D (first sale Mar 25, 2024)

Round Type

Seed

ArlingtonBiotechnology

Quick answer

Praesidia Biotherapeutics raised $500,000 in a Seed round, dated March 25, 2024. Praesidia Biotherapeutics is based in Arlington, Massachusetts, United States.

How much did Praesidia Biotherapeutics raise?
Praesidia Biotherapeutics raised $500,000 in a Seed round on March 25, 2024.
What does Praesidia Biotherapeutics do?
Praesidia is built with the vision of being a patient focused and clinician driven drug development company championing unmet clinical needs.
Where is Praesidia Biotherapeutics based and how big is it?
Praesidia Biotherapeutics is based in Arlington, Massachusetts, United States.
Who are the decision-makers at Praesidia Biotherapeutics?
Fundz holds 1 contact at Praesidia Biotherapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Praesidia Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Elegen raised $33M on May 9, 2024.
  • R3 Vascular raised $87M (Series B) on May 9, 2024.
  • Alzamend Neuro raised $25M (Series A) on May 9, 2024.
  • Eledon raised $50M on May 9, 2024.
  • Aardvark Therapeutics raised $85M (Series C) on May 9, 2024.
  • Frequency Exchange raised $210K (Pre-Seed) on May 9, 2024.

Who to call at Praesidia Biotherapeutics, and when

A new round usually means Praesidia Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Praesidia Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Praesidia Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Praesidia Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Praesidia Biotherapeutics

Location

1167 MASSACHUSETTS AVE.

Arlington, Massachusetts, United States

About

Praesidia is built with the vision of being a patient focused and clinician driven drug development company championing unmet clinical needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Praesidia Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSohang C., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Praesidia Biotherapeutics's next move

See what Strategic adds

Praesidia Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.